Reply to the correspondence letter by Dr. Mitra S. to “alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis”

被引:0
作者
Nilay Hakan
Mustafa Aydin
Ayşegul Zenciroglu
机构
[1] Dr. Sami Ulus Maternity and Children’s Hospital,Department of Neonatology
来源
European Journal of Pediatrics | 2011年 / 170卷
关键词
Bisphosphonates; Alendronate; Osteogenesis Imperfecta; Pamidronate; Etidronate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1357 / 1358
页数:1
相关论文
共 22 条
[1]  
Cho TJ(2005)Efficacy of oral alendronate in children with osteogenesis imperfecta J Pediatr Orthop 25 607-612
[2]  
Choi IH(2008)Intragastric alendronate therapy in two infants with vitamin D intoxication: a new method Clin Toxicol (Phila) 46 300-302
[3]  
Chung CY(2011)Alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis Eur J Pediatr 71 791-814
[4]  
Yoo WJ(2011)Safety of long-term bisphosphonate therapy for the management of osteoporosis Drugs 101 18-26
[5]  
Park MS(1999)Pharmacokinetics of alendronate: an overview Int J Clin Pract Suppl undefined undefined-undefined
[6]  
Park YK(undefined)undefined undefined undefined undefined-undefined
[7]  
Doneray H(undefined)undefined undefined undefined undefined-undefined
[8]  
Ozkan B(undefined)undefined undefined undefined undefined-undefined
[9]  
Caner I(undefined)undefined undefined undefined undefined-undefined
[10]  
Ozkan A(undefined)undefined undefined undefined undefined-undefined